Risk factors for prevalent diabetic retinopathy and proliferative diabetic retinopathy in type 1 diabetes

[1] You W-P(2016)Type 1 diabetes prevalence increasing globally and regionally: the role of natural selection and life expectancy at birth BMJ Open Diabetes Res. Care. 4 481-497

[2] Henneberg M(2010)Chapter 1: epidemiology of type 1 diabetes Endocrinol. Metab. Clin. North Am. 39 122-129

[3] Maahs DM(2015)Global epidemiology of type 1 diabetes in young adults and adults: a systematic review BMC Public Health 15 467-471

[4] West NA(2018)Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank Lancet Diabetes Endocrinol. 6 1136-1144

[5] Lawrence JM(2017)Total serum cholesterol increases risk for development and progression of nonproliferative retinopathy in patients with type 1 diabetes without therapeutic intervention: Prospective, Observational Study Arch. Med Res. 48 515-521

[6] Mayer-Davis EJ(2012)Retinopathy and chronic kidney disease in the Chronic Renal Insufficiency Cohort (CRIC) study Arch. Ophthalmol. (Chic., Ill. 1960). 130 96-105

[7] Diaz-Valencia PA(2011)Identification of independent risk factors for the development of diabetic retinopathy requiring treatment Acta Ophthalmol. 89 465-474

[8] Bougnères P(2018)Factors Associated with Prevalent Diabetic Retinopathy in Chinese Americans: The Chinese American Eye Study Ophthalmology Retina 2 753-758

[9] Valleron A-J(2018)Diabetic retinopathy in type 1 diabetes patients in Western Norway Acta Ophthalmologica 96 424-430

[10] Thomas NJ(2018)Nomogram for prediction of non-proliferative diabetic retinopathy in juvenile-onset type 1 diabetes: a cohort study in an Asian population Sci. Rep. 8 88-93

[1] You W-P(2016)Type 1 diabetes prevalence increasing globally and regionally: the role of natural selection and life expectancy at birth BMJ Open Diabetes Res. Care. 4 481-497

[2] Henneberg M(2010)Chapter 1: epidemiology of type 1 diabetes Endocrinol. Metab. Clin. North Am. 39 122-129

[3] Maahs DM(2015)Global epidemiology of type 1 diabetes in young adults and adults: a systematic review BMC Public Health 15 467-471

[4] West NA(2018)Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank Lancet Diabetes Endocrinol. 6 1136-1144

[5] Lawrence JM(2017)Total serum cholesterol increases risk for development and progression of nonproliferative retinopathy in patients with type 1 diabetes without therapeutic intervention: Prospective, Observational Study Arch. Med Res. 48 515-521

[6] Mayer-Davis EJ(2012)Retinopathy and chronic kidney disease in the Chronic Renal Insufficiency Cohort (CRIC) study Arch. Ophthalmol. (Chic., Ill. 1960). 130 96-105

[7] Diaz-Valencia PA(2011)Identification of independent risk factors for the development of diabetic retinopathy requiring treatment Acta Ophthalmol. 89 465-474

[8] Bougnères P(2018)Factors Associated with Prevalent Diabetic Retinopathy in Chinese Americans: The Chinese American Eye Study Ophthalmology Retina 2 753-758

[9] Valleron A-J(2018)Diabetic retinopathy in type 1 diabetes patients in Western Norway Acta Ophthalmologica 96 424-430

[10] Thomas NJ(2018)Nomogram for prediction of non-proliferative diabetic retinopathy in juvenile-onset type 1 diabetes: a cohort study in an Asian population Sci. Rep. 8 88-93